Era Biology will host global live webinar at 12th July. Due to the fact that WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. ...
Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
“Innovative technology leads the future”, Era Biology closely follows the theme of this exhibition and leads the development of microbial diagnosis to intelligence.
The world’s first au...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
On May 19th, Era Biology host the global live webinar. The webinar talks about three different solutions using fungus (1-3)-β-D Glucan Test to achieve early and rapid diagnosis of invasive fungal d...